ProQR Therapeutics (PRQR) Change in Account Payables (2013 - 2014)

ProQR Therapeutics (PRQR) posted quarterly Change in Account Payables of $505123.4 for Q3 2014, up 293.26% year-on-year from $128445.7 in Q3 2013, and up 293.26% on a QoQ basis from $128445.7 in Q3 2013.

ProQR Therapeutics (PRQR) Change in Account Payables (2013 - 2014) Analysis & Trends

ProQR Therapeutics (PRQR) has reported Change in Account Payables for 2 consecutive years, with $505123.4 the latest figure, recorded in Q3 2014.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Account Payables (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn -42.19 Mn
4 NuCana 279.75 Bn 279.75 Bn - -1.52 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 35.60 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 16.86 Mn
10 ProQR Therapeutics 219.53 Mn 175.72 Mn - -

Historic Data

Download Data
DateValue
Sep 30, 2014 505,123.39
Sep 30, 2014 505,123.39
Sep 30, 2013 128,445.66
Sep 30, 2013 128,445.66